The Traditional Chinese Medicine DangguiBuxue Tang Sensitizes Colorectal Cancer Cells to Chemoradiotherapy

Autor: Ming Cheng Lee, Chih Wen Chi, Tzung Yan Lee, Yu-Jen Chen, Tung Hu Tsai, Shun Ting Chen, Hen-Hong Chang, Ming Ling Hsu, Hui Ru Shieh, Chin Ping Lin, Yin Cheng Lin
Rok vydání: 2016
Předmět:
0301 basic medicine
Oncology
Programmed cell death
medicine.medical_specialty
DangguiBuxue Tang
Colorectal cancer
medicine.medical_treatment
Pharmaceutical Science
colorectal cancer
Vacuole
chemotherapy
Radiation Tolerance
Article
Analytical Chemistry
lcsh:QD241-441
03 medical and health sciences
Inhibitory Concentration 50
0302 clinical medicine
lcsh:Organic chemistry
Internal medicine
Drug Discovery
medicine
Humans
Physical and Theoretical Chemistry
radiotherapy
Chemotherapy
business.industry
Organic Chemistry
Therapeutic effect
Drug Synergism
Chemoradiotherapy
medicine.disease
Antineoplastic Agents
Phytogenic

Radiation therapy
030104 developmental biology
Vacuolization
Chemistry (miscellaneous)
Drug Resistance
Neoplasm

030220 oncology & carcinogenesis
Cancer research
Molecular Medicine
Fluorouracil
Drug Screening Assays
Antitumor

business
HT29 Cells
Drugs
Chinese Herbal
Zdroj: Molecules
Molecules; Volume 21; Issue 12; Pages: 1677
Molecules, Vol 21, Iss 12, p 1677 (2016)
ISSN: 1420-3049
Popis: Chemotherapy is an important treatment modality for colon cancer, and concurrent chemoradiation therapy (CCRT) is the preferred treatment route for patients with stage II and III rectal cancer. We examined whether DangguiBuxue Tang (DBT), a traditional Chinese herbal extract, sensitizes colorectal cancer cells to anticancer treatments. The polysaccharide-depleted fraction of DBT (DBT-PD) contains greater amounts of astragaloside IV (312.626 µg/g) and ferulic acid (1.404 µg/g) than does the original formula. Treatment of the murine colon carcinoma cell line (CT26) with DBT-PD inhibits growth, whereas treatment with comparable amounts of purified astragaloside IV and ferulic acid showed no significant effect. Concurrent treatment with DBT-PD increases the growth inhibitory effect of 5-fluorouracil up to 4.39-fold. DBT-PD enhances the effect of radiation therapy (RT) with a sensitizer enhancement ratio (SER) of up to 1.3. It also increases the therapeutic effect of CCRT on CT26 cells. Cells treated with DBP-PD showed ultrastructural changes characteristic of autophagy, including multiple cytoplasmic vacuoles with double-layered membranes, vacuoles containing remnants of degraded organelles, marked swelling and vacuolization of mitochondria, and autolysosome-like vacuoles. We conclude that DBT-PD induces autophagy-associated cell death in CT26 cells, and may have potential as a chemotherapy or radiotherapy sensitizer in colorectal cancer treatment.
Databáze: OpenAIRE